DeepRhythmAI vs ElucidVivo A.3
AI Verdict
Choose DeepRhythmAI if…
Choose DeepRhythmAI if your primary need is highly accurate and efficient AI-powered detection and classification of cardiac arrhythmias from ECG data. This tool is ideal for healthcare providers seeking to significantly reduce missed diagnoses and streamline their clinical workflows for ECG reporting and analysis, leveraging its advanced CNN and Transformer models.
View DeepRhythmAI →Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if you require detailed, quantitative analysis of arterial plaque composition and stability from CT angiography to stratify atherosclerosis patients. This system is best suited for clinicians who need to optimize treatment decisions based on objective measurements of plaque characteristics, including Lipid-Rich Necrotic Core, validated against histology.
View ElucidVivo A.3 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | DeepRhythmAI | ElucidVivo A.3 |
|---|---|---|
| Pricing | Contact vendor for pricing information | Unknown |
| Deployment | Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid | Cloud and on-premise secure deployment. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ElucidVivo A.3ElucidVivo A.3 is described as a software application with a user interface that 'follows typical clinical workflow patterns', suggesting a direct and ready-to-use experience for clinicians. In contrast, DeepRhythmAI itself 'doesn't have User Interface' and is intended for integrators to build applications, which could lead to variable usability depending on the implementation by third parties.
Clinical Value
DeepRhythmAIBoth tools are FDA-cleared and offer significant clinical value in cardiology. However, DeepRhythmAI demonstrates a highly quantifiable impact by reducing the risk of missed diagnoses of severe arrhythmias by 14 times compared to human technicians, indicating a substantial improvement in patient safety and diagnostic accuracy.
Pricing & Value
TieBoth DeepRhythmAI and ElucidVivo A.3 employ opaque pricing models, requiring direct contact for specific quotes. Without transparent pricing details or publicly available return on investment (ROI) studies, it is not possible to definitively compare their value propositions.
Enterprise Readiness
DeepRhythmAIDeepRhythmAI explicitly details its cloud-based deployment, API availability, data export capabilities, and a comprehensive list of compliance certifications including HIPAA, GDPR, SOC 2, and ISO 27001. This robust set of features and explicit compliance statements indicates a higher level of enterprise readiness compared to ElucidVivo A.3, where deployment options are less definitive and compliance is largely implied.
Innovation
ElucidVivo A.3While DeepRhythmAI utilizes advanced CNN and Transformer models trained on a massive dataset, ElucidVivo A.3 demonstrates greater innovation by offering histologically validated quantitative analysis of arterial plaque composition and stability from CT angiography. This includes the derivation of fractional flow reserve (FFRct), providing novel and predictive insights for personalized atherosclerosis management that extend beyond traditional diagnostic assistance.
Support & Docs
DeepRhythmAIMedicalgorithmics (Tool A's company) provides more explicit details regarding support channels, including a ticketing system for issues and specific contact emails for different inquiries. They also mention providing 'Product information' and Instructions For Use (IFU) or labels, indicating a more structured approach to support and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | DeepRhythmAI | ElucidVivo A.3 |
|---|---|---|
| Name | DeepRhythmAI | ElucidVivo A.3 |
| Company | Medicalgorithmics S.A. | Elucid Bioimaging |
| Description | FDA-cleared, cloud-based AI algorithm that revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians. | FDA-cleared AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography. |
| Primary Function | Cardiac arrhythmia detection and classification from ECG data | Quantitative analysis of arterial plaque composition and stability from CT angiography |
| API Available | yes | Not specified |
| Target Size | Solo to large health systems | Not specified |
| Specialties | Cardiology | Cardiology, Radiology, Vascular Surgery |
Videos
Demos, reviews, and walkthroughs featuring DeepRhythmAI and ElucidVivo A.3.